Beyond Meat, Inc.

WBAG:BYND Stock Report

Market Cap: €306.2m

Beyond Meat Valuation

Is BYND undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BYND when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate BYND's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate BYND's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for BYND?

Key metric: As BYND is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for BYND. This is calculated by dividing BYND's market cap by their current revenue.
What is BYND's PS Ratio?
PS Ratio1x
SalesUS$323.47m
Market CapUS$318.84m

Price to Sales Ratio vs Peers

How does BYND's PS Ratio compare to its peers?

The above table shows the PS ratio for BYND vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.7x
MAN Josef Manner & Comp
0.7xn/a€196.6m
AGR AGRANA Beteiligungs-Aktiengesellschaft
0.2xn/a€693.6m
002069 Zoneco Group
1.5xn/aCN¥2.3b
5JS Indofood Agri Resources
0.3xn/aS$446.7m
BYND Beyond Meat
1x3.7%€318.8m

Price-To-Sales vs Peers: BYND is expensive based on its Price-To-Sales Ratio (1x) compared to the peer average (0.7x).

Price to Sales Ratio vs Industry

How does BYND's PS Ratio compare vs other companies in the European Food Industry?

35 CompaniesPrice / SalesEstimated GrowthMarket Cap
BYND 1.0xIndustry Avg. 0.7xNo. of Companies48PS00.81.62.43.24+
35 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: BYND is expensive based on its Price-To-Sales Ratio (1x) compared to the European Food industry average (0.7x).

Price to Sales Ratio vs Fair Ratio

What is BYND's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BYND PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate BYND's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BYND forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€4.72
€4.98
+5.5%
20.8%€6.64€2.85n/a8
Nov ’25€5.68
€4.92
-13.5%
20.7%€6.40€2.74n/a8
Oct ’25€5.91
€4.63
-21.7%
23.3%€6.27€2.69n/a9
Sep ’25€5.56
€4.63
-16.7%
23.3%€6.27€2.69n/a9
Aug ’25€5.65
€5.38
-4.8%
31.8%€8.30€2.77n/a9
Jul ’25€6.38
€5.38
-15.7%
31.8%€8.30€2.77n/a9
Jun ’25€6.75
€5.38
-20.4%
31.8%€8.30€2.77n/a9
May ’25€6.38
€6.10
-4.3%
34.6%€9.39€2.82n/a10
Apr ’25€7.72
€6.48
-16.1%
35.0%€9.25€2.78n/a10
Mar ’25€10.00
€6.48
-35.2%
35.0%€9.25€2.78n/a10
Feb ’25€6.12
€5.37
-12.3%
29.9%€8.41€2.80n/a10
Jan ’25€7.91
€5.37
-32.1%
29.9%€8.41€2.80n/a10
Dec ’24€6.85
€5.37
-21.5%
29.9%€8.41€2.80n/a10
Nov ’24€5.70
€8.43
+48.0%
41.4%€12.28€2.83€5.6810
Oct ’24€9.06
€9.41
+3.9%
34.1%€12.30€2.84€5.9110
Sep ’24€11.08
€9.71
-12.4%
29.1%€12.02€4.16€5.569
Aug ’24€15.25
€9.52
-37.6%
31.2%€12.80€4.57€5.6512
Jul ’24€12.00
€9.52
-20.7%
31.2%€12.80€4.57€6.3812
Jun ’24€9.48
€10.01
+5.6%
31.2%€13.94€4.65€6.7513
May ’24€12.10
€11.93
-1.4%
38.7%€18.23€4.56€6.3812
Apr ’24€15.06
€11.60
-23.0%
40.1%€18.44€4.61€7.7212
Mar ’24€16.37
€11.74
-28.3%
39.5%€18.96€4.74€10.0013
Feb ’24€14.48
€9.63
-33.5%
30.8%€13.80€4.60€6.1213
Jan ’24€11.41
€12.26
+7.5%
57.7%€33.02€4.72€7.9115
Dec ’23€13.79
€14.49
+5.0%
70.7%€43.55€4.84€6.8516
Nov ’23€15.97
€18.20
+14.0%
57.4%€45.58€5.06€5.7016

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Altria Group

US$96.1b

Through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States.

ALTR

US$54.47

7D

2.6%

1Y

44.1%

Südzucker

€2.3b

Produces and sells sugar products in Germany, rest of the European Union, the United Kingdom, the United States, and internationally.

SZU

€11.19

7D

0.6%

1Y

-22.6%

Tyson Foods

US$22.7b

Operates as a food company worldwide.

TSN

US$61.73

7D

0.9%

1Y

39.3%